

Better sales from its dermatology and post-abdominal surgery treatment products helped AIM drug company Alliance Pharma hit profit expectations for 20...


Thanks to lower costs and slow and steady sales growth, drug investor Alliance Pharma made a strong start to the year. With sales up 4% to £22.8m in ...


Aggreko: UBS cuts target price from 1975p to 1850p downgrading from buy to neutral. JP Morgan revises target price from 1870p to 1800p and retains a n...


Severn Trent is one of a dwindling group of remaining publicly listed water companies. For The Times´s Tempus the bidding for the water firm is not ye...


Aggreko: Goldman Sachs cuts target price from 2425p to 2125p, while retaining its buy recommendation. Alliance Pharma: FinnCap shifts target price fr...